Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature (Q61814448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

0 references

2 references

3 November 2020

13 December 2020

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

4 references

20 June 2019

16 September 2019

7 October 2019

3 November 2020

1 reference

16 September 2019

human digestive system

1 reference

7 October 2019

1 reference

3 November 2020

disease susceptibility

1 reference

13 December 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Edda Russo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

author name string

Ivana Milosevic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Ankica Vujovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Marina Djelic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Milos Korac

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Aleksandra Radovanovic Spurnic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Ivana Gmizic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Olja Stevanovic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Vladimir Djordjevic

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Nebojsa Lekic

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

Amedeo Amedei

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

language of work or name

English

0 references

publication date

17 January 2019

6 references

20 June 2019

16 September 2019

7 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

3 November 2020

13 December 2020

International Journal of Molecular Sciences

6 references

20 June 2019

16 September 2019

7 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

3 November 2020

13 December 2020

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution

19 April 2020

page(s)

395

0 references

copyright license

5 references

20 June 2019

16 September 2019

7 October 2019

3 November 2020

13 December 2020

0 references

Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat

1 reference

12 December 2020

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

12 December 2020

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

12 December 2020

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

12 December 2020

Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension

1 reference

12 December 2020

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

1 reference

12 December 2020

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

1 reference

12 December 2020

Protective effect of selenium-enriched Lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms

1 reference

12 December 2020

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

1 reference

12 December 2020

The gut flora as a forgotten organ

1 reference

12 December 2020

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

1 reference

12 December 2020

Pathogenetic mechanisms of hepatic encephalopathy

1 reference

12 December 2020

Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome

1 reference

12 December 2020

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

1 reference

12 December 2020

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

1 reference

12 December 2020

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

12 December 2020

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

1 reference

12 December 2020

Towards the human intestinal microbiota phylogenetic core

1 reference

12 December 2020

The changing pattern of epidemiology in hepatocellular carcinoma

1 reference

12 December 2020

Tissue-specific function of farnesoid X receptor in liver and intestine

1 reference

12 December 2020

Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy

1 reference

12 December 2020

Characterization of fecal microbial communities in patients with liver cirrhosis

1 reference

12 December 2020

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis

1 reference

12 December 2020

Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma

1 reference

12 December 2020

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

1 reference

12 December 2020

Probiotics for patients with hepatic encephalopathy

1 reference

12 December 2020

Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach

1 reference

12 December 2020

Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota.

1 reference

12 December 2020

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

1 reference

12 December 2020

Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy

1 reference

12 December 2020

Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

12 December 2020

Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome

1 reference

12 December 2020

Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy

1 reference

12 December 2020

Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats

1 reference

12 December 2020

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

1 reference

12 December 2020

Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease

1 reference

12 December 2020

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

1 reference

12 December 2020

Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents

1 reference

12 December 2020

Microbiota-liver axis in hepatic disease.

1 reference

12 December 2020

Chronic ethanol consumption alters mammalian gastrointestinal content metabolites.

1 reference

12 December 2020

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

1 reference

12 December 2020

The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury

1 reference

12 December 2020

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

1 reference

12 December 2020

Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial

1 reference

12 December 2020

Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach

1 reference

12 December 2020

Altered profile of human gut microbiome is associated with cirrhosis and its complications

1 reference

12 December 2020

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

1 reference

12 December 2020

Epidemiology and natural history of hepatitis C virus infection

1 reference

12 December 2020

Alterations of the human gut microbiome in liver cirrhosis

1 reference

12 December 2020

Evaluation of bacterial translocation in patients with chronic HCV infection.

1 reference

12 December 2020

Role of farnesoid X receptor in inflammation and resolution.

1 reference

12 December 2020

Gut-liver axis in alcoholic liver disease

1 reference

12 December 2020

Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease

1 reference

12 December 2020

1 reference

12 December 2020

Gut microbiota and liver diseases

1 reference

12 December 2020

Alcoholic liver disease: the gut microbiome and liver cross talk

1 reference

12 December 2020

Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease

1 reference

12 December 2020

Gut microbiota: its role in hepatic encephalopathy

1 reference

12 December 2020

New-found link between microbiota and obesity

1 reference

12 December 2020

Gut Microbiota and Hepatocellular Carcinoma

1 reference

12 December 2020

Gut microbiome and kidney disease: a bidirectional relationship

1 reference

12 December 2020

The role of Gut Microbiota in the development of obesity and Diabetes

1 reference

12 December 2020

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

1 reference

12 December 2020

Bile acid receptor agonists INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice

1 reference

12 December 2020

Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.

1 reference

12 December 2020

Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma

1 reference

12 December 2020

Gut microbiome alterations in patients with stage 4 hepatitis C.

1 reference

12 December 2020

Interaction between gut microbiota and toll-like receptor: from immunity to metabolism

1 reference

12 December 2020

Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study

1 reference

12 December 2020

Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.

1 reference

12 December 2020

Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy

1 reference

12 December 2020

Reduction of Aflatoxin B1 Toxicity by Lactobacillus plantarum C88: A Potential Probiotic Strain Isolated from Chinese Traditional Fermented Food "Tofu"

1 reference

12 December 2020

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis

1 reference

12 December 2020

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management

1 reference

12 December 2020

The intestinal microbiome and paediatric liver disease

1 reference

12 December 2020

Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy

1 reference

12 December 2020

Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.

1 reference

12 December 2020

Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial

1 reference

12 December 2020

Gut microbiota changes and chronic hepatitis C virus infection.

1 reference

12 December 2020

Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease

1 reference

12 December 2020

Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease

1 reference

12 December 2020

Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction

1 reference

12 December 2020

Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients

1 reference

12 December 2020

Impact of Omega-3 Fatty Acids on the Gut Microbiota.

1 reference

12 December 2020

Microbiota, a key player in alcoholic liver disease.

1 reference

12 December 2020

Diet Affects Gut Microbiota and Modulates Hospitalization Risk Differentially In an International Cirrhosis Cohort

1 reference

12 December 2020

Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study

1 reference

12 December 2020

Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

1 reference

12 December 2020

Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota.

1 reference

12 December 2020

Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection

1 reference

12 December 2020

The Human Gut Microbiome - A Potential Controller of Wellness and Disease

1 reference

12 December 2020

Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver?

1 reference

12 December 2020

Clinical impact of microbiome in patients with decompensated cirrhosis

1 reference

12 December 2020

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease

1 reference

12 December 2020

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation

1 reference

12 December 2020

Epidemiology and Management of Hepatocellular Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS20020395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30658519 AND SRC:MED&resulttype=core&format=json

19 April 2020

PubMed publication ID

30658519

1 reference